-
Signature
-
/s/ Brian Grube, Attorney-in-Fact
-
Issuer symbol
-
INTA
-
Transactions as of
-
03 Mar 2025
-
Net transactions value
-
-$457,950
-
Form type
-
4
-
Filing time
-
05 Mar 2025, 16:08:03 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INTA |
Common Stock |
Options Exercise |
$59,600 |
+8,000 |
+0.15% |
$7.45 |
5,244,895 |
03 Mar 2025 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Sale |
$6,296 |
-100 |
-0% |
$62.96 |
5,244,795 |
03 Mar 2025 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Sale |
$151,037 |
-2,385 |
-0.05% |
$63.33 |
5,242,410 |
03 Mar 2025 |
Direct |
F1, F2 |
| transaction |
INTA |
Common Stock |
Sale |
$32,283 |
-500 |
-0.01% |
$64.57 |
5,241,910 |
03 Mar 2025 |
Direct |
F1, F2 |
| transaction |
INTA |
Common Stock |
Sale |
$310,728 |
-4,755 |
-0.09% |
$65.35 |
5,237,155 |
03 Mar 2025 |
Direct |
F1, F2 |
| transaction |
INTA |
Common Stock |
Sale |
$17,206 |
-260 |
-0% |
$66.18 |
5,236,895 |
03 Mar 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
INTA |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-8,000 |
-0.69% |
$0.000000 |
1,154,000 |
03 Mar 2025 |
Common Stock |
8,000 |
$7.45 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: